Spotlight

Dr Celia Caulcott appointed Vice-Provost (Enterprise)

Dr Celia Caulcott has been appointed the next Vice-Provost (Enterprise) at UCL, with effect from 1 October 2015.

The Office of the Vice-Provost (Enterprise) is responsible for delivering UCL’s Enterprise agenda with the greatest economic and societal impact. Vice-Provosts are members of the Provost's senior management team. 

Read the full article



follow us on twitter


Spirogen sold to AstraZeneca

16 October 2013

AstraZeneca to pay $440m for UK biotech business
Pharmaceutical group makes acquisition in oncology group spun out of university
Read: Guardian

AstraZeneca Buys Spirogen for $440 Million
MedImmune Unit Also Enters Deal with ADC Therapeutics
Read: Wall Street Journal